Resources
The risk minimisation materials for Accord thalidomide, lenalidomide and pomalidomide are available to download below
This website is for UK Healthcare Professionals.
This website is for UK Healthcare Professionals.
Resources
The risk minimisation materials for Accord thalidomide, lenalidomide and pomalidomide are available to download below
Materials available as editable pdfs:
| Medicinal Name | Material | Description | Download |
|---|---|---|---|
| Lenalidomide | Healthcare Professional’s Pack | Contains the complete information needed by healthcare professionals for prescribing and dispensing Accord Lenalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient. The pack contains all educational risk minimisation materials | Download PDF |
| Thalidomide | Healthcare Professional’s Pack | Contains the complete information needed by healthcare professionals for prescribing and dispensing Accord Thalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient. The pack contains all educational risk minimisation materials | Download PDF |
| Pomalidomide | Healthcare Professional’s Pack | Contains the complete information needed by healthcare professionals for prescribing and dispensing Accord Pomalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient. The pack contains all educational risk minimisation materials | Download PDF |
| Lenalidomide | Pharmacy Registration Form (PRF) | Form for completion by the Chief Pharmacist, or their Appointed Deputy. Only pharmacies registered with Accord via the PRF can order and dispense Accord Lenalidomide | Download PDF |
| Thalidomide | Pharmacy Registration Form (PRF) | Form for completion by the Chief Pharmacist, or their Appointed Deputy. Only pharmacies registered with Accord via the PRF can order and dispense Accord Thalidomide | Download PDF |
| Pomalidomide | Pharmacy Registration Form (PRF) | Form for completion by the Chief Pharmacist, or their Appointed Deputy. Only pharmacies registered with Accord via the PRF can order and dispense Accord Pomalidomide | Download PDF |
| Lenalidomide | Prescription Authorisation Form (PAF) | Form for completion by the prescriber and pharmacist. Each prescription of Accord Lenalidomide must be accompanied by a newly completed Prescription Authorisation Form (PAF) | Download PDF |
| Thalidomide | Prescription Authorisation Form (PAF) | Form for completion by the prescriber and pharmacist. Each prescription of Accord Thalidomide must be accompanied by a newly completed Prescription Authorisation Form (PAF) | Download PDF |
| Pomalidomide | Prescription Authorisation Form (PAF) | Form for completion by the prescriber and pharmacist. Each prescription of Accord Pomalidomide must be accompanied by a newly completed Prescription Authorisation Form (PAF) | Download PDF |
| Lenalidomide | Male Risk Awareness Form (RAF) | Form for completion by the prescriber for each male patient prior to the initiation of their Lenalidomide treatment. It is mandatory that all males receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Thalidomide | Male Risk Awareness Form (RAF) | Form for completion by the prescriber for each male patient prior to the initiation of their Thalidomide treatment. It is mandatory that all males receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Pomalidomide | Male Risk Awareness Form (RAF) | Form for completion by the prescriber for each male patient prior to the initiation of their Pomalidomide treatment. It is mandatory that all males receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Lenalidomide | Women of Childbearing Potential (WCBP) Risk Awareness Form (RAF) | Form for completion by the prescriber for each woman of childbearing potential prior to the initiation of their Lenalidomide treatment. It is mandatory that women of childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Thalidomide | Women of Childbearing Potential (WCBP) Risk Awareness Form (RAF) | Form for completion by the prescriber for each woman of childbearing potential prior to the initiation of their Thalidomide treatment. It is mandatory that women of childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Pomalidomide | Women of Childbearing Potential (WCBP) Risk Awareness Form (RAF) | Form for completion by the prescriber for each woman of childbearing potential prior to the initiation of their Pomalidomide treatment. It is mandatory that all women of childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Lenalidomide | Women of Non-childbearing Potential (WNCBP) Risk Awareness Form (RAF) | Form for completion by the prescriber for each woman of non-childbearing potential prior to the initiation of their Lenalidomide treatment. It is mandatory that women of non-childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Thalidomide | Women of Non-childbearing Potential (WNCBP) Risk Awareness Form (RAF) | Form for completion by the prescriber for each woman of non-childbearing potential prior to the initiation of their Thalidomide treatment. It is mandatory that women of non-childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
| Pomalidomide | Women of Non-childbearing Potential (WNCBP) Risk Awareness Form (RAF) | Form for completion by the prescriber for each woman of non-childbearing potential prior to the initiation of their Pomalidomide treatment. It is mandatory that all women of non-childbearing potential receive counselling and education to be made aware of the risks with this medicine | Download PDF |
Materials available for download and print:
| Medicinal Name | Material | Description | Download |
|---|---|---|---|
| Lenalidomide | Information for Healthcare Professionals | Contains the information needed by healthcare professionals for prescribing and dispensing Accord Lenalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient | Download PDF |
| Thalidomide | Information for Healthcare Professionals | Contains the information needed by healthcare professionals for prescribing and dispensing Accord Thalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient | Download PDF |
| Pomalidomide | Information for Healthcare Professionals | Contains the information needed by healthcare professionals for prescribing and dispensing Accord Pomalidomide, including information about the Pregnancy Prevention Programme (PPP). It is a requirement that healthcare professionals read and understand the PPP prior to prescribing and dispensing to any patient | Download PDF |
| Lenalidomide | Algorithm | The Algorithm provides high level steps for the process of pharmacy registration and the dispensing of lenalidomide | Download PDF |
| Thalidomide | Algorithm | The Algorithm provides high level steps for the process of pharmacy registration and the dispensing of thalidomide | Download PDF |
| Pomalidomide | Algorithm | The Algorithm provides high level steps for the process of pharmacy registration and the dispensing of pomalidomide | Download PDF |
| Lenalidomide | Information for Patients | Information to be given to each patient receiving treatment to provide important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Lenalidomide along with how to report any side effects. | Download PDF |
| Thalidomide | Information for Patients | Information to be given to each patient receiving treatment to provide important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Thalidomide along with how to report any side effects. | Download PDF |
| Pomalidomide | Information for Patients | Information to be given to each patient receiving treatment to provide important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Pomalidomide along with how to report any side effects. | Download PDF |
| Lenalidomide | Patient Information Card | Card to be given to each patient receiving treatment, as it provides important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Lenalidomide along with how to report any side effects. | Download PDF |
| Thalidomide | Patient Information Card | Card to be given to each patient receiving treatment, as it provides important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Thalidomide along with how to report any side effects. | Download PDF |
| Pomalidomide | Patient Information Card | Card to be given to each patient receiving treatment, as it provides important details about the Pregnancy Prevention Programme, including what the patient needs to be aware of before, during and after taking Accord Pomalidomide along with how to report any side effects. | Download PDF |
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Accord-UK Ltd on 01271 385257 or email [email protected].
UK-03777 April 2024
UK-03777 June 2025
Copyright 2025 All rights reserved.
For UK Healthcare Professionals
If you are a UK healthcare professional and would like more information on thalidomide, lenalidomide or pomalidomide from Accord, please click here
Report Adverse Events
Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.
Adverse events should also be reported to Accord-UK Ltd:
Tel: 01271 385257
Email: [email protected]
For more information on thalidomide, lenalidomide or pomalidomide from Accord, please click below
Site intended for a UK audience only. UK-03777 June 2025